A review targeting the infection by CHIKV using computational and experimental approaches

References

• Abbad, A., Perera, R. A., Anga, L., Faouzi, A., Minh, N. N. T., Malik, S. M. M. R., Iounes, N., Maaroufi, A., Van Kerkhove, M. D., Peiris, M., & Nourlil, J. (2019). Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Eurosurveillance, 24(48), 43–50. https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900244
   Web of Science ®Google Scholar
• Agarwal, T., Asthana, S., & Bissoyi, A. (2015). Molecular modeling and docking study to elucidate novel Chikungunya virus nsP2 protease inhibitors. Indian Journal of Pharmaceutical Sciences, 77(4), 453–460. https://doi.org/10.4103/0250-474x.164769
   PubMed Web of Science ®Google Scholar
• Ahmadi, A., Hassandarvish, P., Lani, R., Yadollahi, P., Jokar, A., Bakar, S. A., & Zandi, K. (2016). Inhibition of chikungunya virus replication by hesperetin and naringenin. RSC Advances, 6(73), 69421–69430. https://doi.org/10.1039/C6RA16640G
   Web of Science ®Google Scholar
• Ahmed, A., Ali, Y., Elmagboul, B., Mohamed, O., Elduma, A., Bashab, H., Mahamoud, A., Khogali, H., Elaagip, A., & Higazi, T. (2019). Dengue fever in the Darfur Area, Western Sudan. Emerging Infectious Diseases, 25(11), 2126–2126. https://doi.org/10.3201/eid2511.181766
   PubMed Web of Science ®Google Scholar
• Al-Anazi, M., Al-Najjar, B. O., & Khairuddean, M. (2018). Structure-based drug design studies toward the discovery of novel chalcone derivatives as potential epidermal growth factor receptor (EGFR) inhibitors. Molecules, 23(12), 3203. https://doi.org/10.3390/molecules23123203
   PubMed Web of Science ®Google Scholar
• Allard, P.-M., Leyssen, P., Martin, M.-T., Bourjot, M., Dumontet, V., Eydoux, C., Guillemot, J.-C., Canard, B., Poullain, C., Guéritte, F., & Litaudon, M. (2012). Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri. Phytochemistry, 84, 160–168. https://doi.org/10.1016/j.phytochem.2012.07.023
   PubMed Web of Science ®Google Scholar
• Bachal, R., Alagarasu, K., Singh, A., Salunke, A., Shah, P., & Cecilia, D. (2015). Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever. Archives of Virology, 160(10), 2435–2443. https://doi.org/10.1007/s00705-015-2519-7
   PubMed Web of Science ®Google Scholar
• Balzarini, J., Ruchko, E. A., Zakharova, E. K., Kameneva, I. Y., & Nawrozkij, M. B. (2014). Structural analogs of umifenovir. 1. Synthesis and biological activity of ethyl 5-hydroxy-1-methyl-2-(trans-2-phenylcyclopropyl)-1H-indole-3-carboxylate. Chemistry of Heterocyclic Compounds, 50(4), 489–495. https://doi.org/10.1007/s10593-014-1499-y
   PubMed Web of Science ®Google Scholar
• Bassetto, M., De Burghgraeve, T., Delang, L., Massarotti, A., Coluccia, A., Zonta, N., Gatti, V., Colombano, G., Sorba, G., Silvestri, R., Tron, G. C., Neyts, J., Leyssen, P., & Brancale, A. (2013). Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. Antiviral Research, 98(1), 12–18. https://doi.org/10.1016/j.antiviral.2013.01.002
   PubMed Web of Science ®Google Scholar
• Bhakat, S., & Soliman, M. E. (2015). Chikungunya virus (CHIKV) inhibitors from natural sources: A medicinal chemistry perspective. Journal of Natural Medicines, 69(4), 451–462. https://doi.org/10.1007/s11418-015-0910-z
   PubMed Web of Science ®Google Scholar
• Blaising, J., Polyak, S. J., & Pecheur, E. I. (2014). Arbidol as a broad-spectrum antiviral: An update. Antiviral Research, 107, 84–94. https://doi.org/10.1016/j.antiviral.2014.04.006
   PubMed Web of Science ®Google Scholar
• Boriskin, Y. S., Leneva, I. A., Pecheur, E. I., & Polyak, S. J. (2008). Arbidol: A broad-spectrum antiviral compound that blocks viral fusion. Current Medicinal Chemistry, 15(10), 997–1005. https://doi.org/10.2174/092986708784049658
   PubMed Web of Science ®Google Scholar
• Bourjot, M., Leyssen, P., Eydoux, C., Guillemot, J.-C., Canard, B., Rasoanaivo, P., Guéritte, F., & Litaudon, M. (2012). Chemical constituents of Anacolosa pervilleana and their antiviral activities. Fitoterapia, 83(6), 1076–1080. https://doi.org/10.1016/j.fitote.2012.05.004
   PubMed Web of Science ®Google Scholar
• Briolant, S., Garin, D., Scaramozzino, N., Jouan, A., & Crance, J. M. (2004). In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: Synergistic effect of interferon-alpha and ribavirin combination. Antiviral Research, 61(2), 111–117. https://doi.org/10.1016/j.antiviral.2003.09.005
   PubMed Web of Science ®Google Scholar
• Burt, F. J., Chen, W., Miner, J. J., Lenschow, D. J., Merits, A., Schnettler, E., Kohl, A., Rudd, P. A., Taylor, A., Herrero, L. J., Zaid, A., Ng, L. F. P., & Mahalingam, S. (2017). Chikungunya virus: An update on the biology and pathogenesis of this emerging pathogen. The Lancet Infectious Diseases, 17(4), E107–E117. https://doi.org/10.1016/S1473-3099(16)30385-1
   PubMed Web of Science ®Google Scholar
• Busch, M., & Erickson, G. (2015). An overview of Chikungunya virus. Jaapa: Official Journal of the American Academy of Physician Assistants, 28(10), 54–57. https://doi.org/10.1097/01.JAA.0000470441.99693.e1
   PubMedGoogle Scholar
• Caglioti, C., Lalle, E., Castilletti, C., Carletti, F., Capobianchi, M. R., & Bordi, L. (2013). Chikungunya virus infection: An overview. The New Microbiologica, 36(3), 211–227.
   PubMed Web of Science ®Google Scholar
• Cirne-Santos, C. C., Barros, C. d S., Nogueira, C. C. R., Azevedo, R. C., Yamamoto, K. A., Meira, G. L. S., Vasconcelos, Z. F. M. d., Ratcliffe, N. A., Teixeira, V. L., Schmidt-Chanasit, J., Ferreira, D. F., & Paixão, I. C. N. D. P. (2019). Inhibition by marine algae of Chikungunya virus isolated from patients in a recent disease outbreak in Rio de Janeiro. Frontiers in Microbiology, 10, 1-11. https://doi.org/10.3389/fmicb.2019.02426
   Google Scholar
• Cummings, M. D., & Sekharan, S. (2019). Structure-based macrocycle design in small-molecule drug discovery and simple metrics to identify opportunities for macrocyclization of small-molecule ligands. Journal of Medicinal Chemistry, 62(15), 6843–6853. https://doi.org/10.1021/acs.jmedchem.8b01985
   PubMed Web of Science ®Google Scholar
• da Rocha, L. F., de Lima, H. D., Correia, R. M., Freitas, M. R. D. A., de Melo, P. R. S., & de Mattos, A. G. L. (2017). Electroneurographic findings in patients with subacute/chronic articular symptoms of Chikungunya fever and neuropathic complaints preliminary results. Annals of the Rheumatic Diseases, 76, 990–991.
   Web of Science ®Google Scholar
• Dawood, S., Zarina, S., & Bano, S. (2014). Docking studies of antidepressants against single crystal structure of tryptophan 2,3-dioxygenase using Molegro Virtual Docker software. Pakistan Journal of Pharmaceutical Sciences, 27(5 Spec no), 1529–1539.
   PubMed Web of Science ®Google Scholar
• de Vries, E., Du, W. J., Guo, H. B., & de Haan, C. A. M. (2020). Influenza A virus hemagglutinin-neuraminidase-receptor balance: Preserving virus motility. Trends in Microbiology, 28(1), 57–67. https://doi.org/10.1016/j.tim.2019.08.010
   PubMed Web of Science ®Google Scholar
• Deeba, F., Malik, M. Z., Naqvi, I. H., Haider, M. S. H., Shafat, Z., Sinha, P., Ishrat, R., Ahmed, A., & Parveen, S. (2017). Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: In silico structural modeling, docking and molecular dynamic studies. Virusdisease, 28(1), 39–49. https://doi.org/10.1007/s13337-016-0356-2
   PubMedGoogle Scholar
• Delang, L., Segura Guerrero, N., Tas, A., Quérat, G., Pastorino, B., Froeyen, M., Dallmeier, K., Jochmans, D., Herdewijn, P., Bello, F., Snijder, E. J., de Lamballerie, X., Martina, B., Neyts, J., van Hemert, M. J., & Leyssen, P. (2014). Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. The Journal of Antimicrobial Chemotherapy, 69(10), 2770–2784. https://doi.org/10.1093/jac/dku209
   PubMed Web of Science ®Google Scholar
• Delang, L., Yen, P., Vazeille, M., Neyts, J., & Failloux, A. (2017). Antiviral drug-resistant Chikungunya viruses can be transmitted by their mosquito vectors. Tropical Medicine & International Health, 22, 15–16.
   Web of Science ®Google Scholar
• Delogu, I., Pastorino, B., Baronti, C., Nougairede, A., Bonnet, E., & de Lamballerie, X. (2011). In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antiviral Research, 90(3), 99–107. https://doi.org/10.1016/j.antiviral.2011.03.182
   PubMed Web of Science ®Google Scholar
• Di Mola, A., Peduto, A., La Gatta, A., Delang, L., Pastorino, B., Neyts, J., Leyssen, P., de Rosa, M., & Filosa, R. (2014). Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication. Bioorganic & Medicinal Chemistry, 22(21), 6014–6025. https://doi.org/10.1016/j.bmc.2014.09.013
   PubMed Web of Science ®Google Scholar
• Durgesh, K., Mahendra, K. M., Kamlesh, K., Rajan, P., Abhilash, J., & Prashant, S. (2020). In-silico prediction of novel drug-target complex of nsP3 of CHIKV through molecular dynamic simulation. Heliyon, 6(8), e04720.
   PubMed Web of Science ®Google Scholar
• Dyer, O. (2019). Polio: WHO declares type 3 poliovirus eradicated after 31 year campaign. British Medical Journal, 367:I6201.
   Google Scholar
• Ekins, S., Mestres, J., & Testa, B. (2007). In silico pharmacology for drug discovery: Methods for virtual ligand screening and profiling. British Journal of Pharmacology, 152(1), 9–20. https://doi.org/10.1038/sj.bjp.0707305
   PubMed Web of Science ®Google Scholar
• Evans-Gilbert, T. (2020). Vertically transmitted chikungunya, Zika and dengue virus infections: The pathogenesis from mother to fetus and the implications of co-infections and vaccine development. International Journal of Pediatrics & Adolescent Medicine, 7(3), 107–111. https://doi.org/10.1016/j.ijpam.2019.05.004
   PubMedGoogle Scholar
• Farias, L. A. B. G., Neto, R. D. P., & Campos, E. D. (2019). Chikungunya fever and mental illness: A poorly understood relationship needing additional study. Archives of Clinical Psychiatry, 46(4), 1–1. https://doi.org/10.1590/0101-60830000000206
   Web of Science ®Google Scholar
• Fink, S. L., Vojtech, L., Wagoner, J., Slivinski, N. S. J., Jackson, K. J., Wang, R., Khadka, S., Luthra, P., Basler, C. F., & Polyak, S. J. (2018). The antiviral drug arbidol inhibits Zika virus. Scientific Reports, 8(1), 8989. https://doi.org/10.1038/s41598-018-27224-4
   PubMedGoogle Scholar
• Finney, L. J., Belchamber, K. B. R., Fenwick, P. S., Kemp, S. V., Edwards, M. R., Mallia, P., Donaldson, G., Johnston, S. L., Donnelly, L. E., & Wedzicha, J. A. (2019). Human rhinovirus impairs the innate immune response to bacteria in alveolar macrophages in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 199(12), 1496–1507. https://doi.org/10.1164/rccm.201806-1095OC
   PubMed Web of Science ®Google Scholar
• Fowkes, F. G. R., Price, J. F., Stewart, M. C. W., Butcher, I., Leng, G. C., & Pell, A. C. H. (2010). Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index a randomized controlled trial. JAMA, 303(9), 841–848. https://doi.org/10.1001/jama.2010.221
   PubMed Web of Science ®Google Scholar
• Fox, J. M., & Diamond, M. S. (2016). Immune-mediated protection and pathogenesis of Chikungunya virus. Journal of Immunology, 197(11), 4210–4218. https://doi.org/10.4049/jimmunol.1601426
   PubMed Web of Science ®Google Scholar
• Ganesan, V. K., Duan, B., & Reid, S. P. (2017). Chikungunya virus: Pathophysiology, mechanism, and modeling. Viruses, 9(12), 368. https://doi.org/10.3390/v9120368
   PubMed Web of Science ®Google Scholar
• Gao, Y. N., Goonawardane, N., Ward, J., Tuplin, A., & Harris, M. (2019). Multiple roles of the non-structural protein 3 (nsP3) alphavirus unique domain (AUD) during Chikungunya virus genome replication and transcription. PLOS Pathogens, 15(1), e1007239. https://doi.org/10.1371/journal.ppat.1007239
   PubMed Web of Science ®Google Scholar
• Gasque, P., Couderc, T., Lecuit, M., Roques, P., & Ng, L. F. (2015). Chikungunya virus pathogenesis and immunity. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.), 15(4), 241–249. https://doi.org/10.1089/vbz.2014.1710
   PubMed Web of Science ®Google Scholar
• Ghildiyal, R., Gupta, S., Gabrani, R., Joshi, G., Gupta, A., Chaudhary, V. K., & Gupta, V. (2019). In silico study of chikungunya polymerase, a potential target for inhibitors. Virusdisease, 30(3), 394–402. https://doi.org/10.1007/s13337-019-00547-0
   PubMedGoogle Scholar
• Gomperts, R., Frisch, M., Scalmani, G., & Leback, B. (2014). Current status of the project to enable Gaussian 09 on GPGPUs. Abstracts of Papers of the American Chemical Society, 1–20.
   Web of Science ®Google Scholar
• Goupil, B. A., & Mores, C. N. (2016). A review of Chikungunya virus-induced arthralgia: Clinical manifestations, therapeutics, and pathogenesis. The Open Rheumatology Journal, 10(1), 129–140. https://doi.org/10.2174/1874312901610010129
   PubMedGoogle Scholar
• Gowen, B., Barnard, D., Wong, M.-H., Larson, D., Wu, J., Ennis, J., Morrey, J., & Turner, J. (2010). Single-dose intranasal delivery with DEF201 (Adenovirus Vectored Mouse Interferon-alpha) protects against phlebovirus and sars coronavirus challenge. Antiviral Research, 86(1), A34. https://doi.org/10.1016/j.antiviral.2010.02.376
   Web of Science ®Google Scholar
• Gratia, M., Vende, P., Charpilienne, A., Baron, H. C., Laroche, C., Sarot, E., Pyronnet, S., Duarte, M., & Poncet, D. (2016). Challenging the roles of NSP3 and untranslated regions in rotavirus mRNA translation. Plos One, 11(1), e0145998. https://doi.org/10.1371/journal.pone.0145998
   PubMed Web of Science ®Google Scholar
• Gupta, A., Gandhimathi, A., Sharma, P., & Jayaram, B. (2007). ParDOCK: An all atom energy based Monte Carlo docking protocol for protein-ligand complexes. Protein and Peptide Letters, 14(7), 632–646. https://doi.org/10.2174/092986607781483831
   PubMed Web of Science ®Google Scholar
• Hashem, A. M., Algaissi, A., Agrawal, A. S., Al-Amri, S. S., Alhabbab, R. Y., Sohrab, S. S., S Almasoud, A., Alharbi, N. K., Peng, B.-H., Russell, M., Li, X., & Tseng, C.-T. K. (2019). A highly immunogenic, protective, and safe adenovirus-based vaccine expressing middle east respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human dipeptidyl peptidase 4 mouse model. The Journal of Infectious Diseases, 220(10), 1558–1567. https://doi.org/10.1093/infdis/jiz137
   PubMed Web of Science ®Google Scholar
• Haviernik, J., Štefánik, M., Fojtíková, M., Kali, S., Tordo, N., Rudolf, I., Hubálek, Z., Eyer, L., & Ruzek, D. (2018). Arbidol (Umifenovir): A broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses. Viruses, 10(4), 184. https://doi.org/10.3390/v10040184
   PubMed Web of Science ®Google Scholar
• Hazama, K., Shiihara, T., Tsukagoshi, H., Matsushige, T., Dowa, Y., & Watanabe, M. (2019). Rhinovirus-associated acute encephalitis/encephalopathy and cerebellitis. Brain & Development, 41(6), 551–554. https://doi.org/10.1016/j.braindev.2019.02.014
   PubMed Web of Science ®Google Scholar
• Horie, Y., Nakagomi, O., Koshimura, Y., Nakagomi, T., Suzuki, Y., Oka, T., Sasaki, S., Matsuda, Y., & Watanabe, S. (1999). Diarrhea induction by rotavirus NSP4 in the homologous mouse model system. Virology, 262(2), 398–407. https://doi.org/10.1006/viro.1999.9912
   PubMed Web of Science ®Google Scholar
• Hsu, K. C., Chen, Y. F., Lin, S. R., & Yang, J. M. (2011). iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinformatics, 12(Suppl 1), S33. https://doi.org/10.1186/1471-2105-12-S1-S33
   PubMed Web of Science ®Google Scholar
• Hwu, J. R., Kapoor, M., Tsay, S.-C., Lin, C.-C., Hwang, K. C., Horng, J.-C., Chen, I.-C., Shieh, F.-K., Leyssen, P., & Neyts, J. (2015). Benzouracil-coumarin-arene conjugates as inhibiting agents for chikungunya virus. Antiviral Research, 118, 103–109. https://doi.org/10.1016/j.antiviral.2015.03.013
   PubMed Web of Science ®Google Scholar
• Ismail, A. A., Mahboob, T., Raju, C. S., & Sekaran, S. D. (2019). Zika virus modulates blood-brain barrier of brain microvascular endothelial cells. Tropical Biomedicine, 36(4), 888–897.
   PubMed Web of Science ®Google Scholar
• Jacome-Santos, H., Amanajas, T. D., Gomes, S. T. M., Machado, L. F. A., Neto, A. R. L. P., & Alves, S. D. (2020). Epstein-Barr virus (EBV) in periodontal sites of human immunodeficiency virus (HIV)-positive individuals in North Brazil: A cross-sectional study. Quintessence International, 51(1), 18–26.
   PubMed Web of Science ®Google Scholar
• Jagannadh, B., Kunwar, A. C., Thangavelu, R. P., & Osawa, E. (1996). New technique for conformational sampling of cyclic molecules using the AMBER force field: Application to 18-crown-6. The Journal of Physical Chemistry, 100(34), 14339–14342. https://doi.org/10.1021/jp960929z
   Web of Science ®Google Scholar
• Jain, J., Kumari, A., Somvanshi, P., Grover, A., Pai, S., & Sunil, S. (2017). In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus. F1000Research, 6, 1601. https://doi.org/10.12688/f1000research.12301.2
   PubMedGoogle Scholar
• Jarrahpour, A., Motamedifar, M., Zarei, M., Youssoufi, M. H., Mimouni, M., Chohan, Z. H., & Hadda, T. B. (2010). Petra, osiris, and molinspiration together as a guide in drug design: Predictions and correlation structure/antibacterial activity relationships of new N-sulfonyl monocyclic-lactams. Phosphorus Sulfur and Silicon and the Related Elements, 185(2), 491–497. https://doi.org/10.1080/10426500902953953
   Web of Science ®Google Scholar
• Jeanne, M., Eve, S., Pasquier, J., Blaizot, X., Turck, M., & Raginel, T. (2019). Human papillomaviruses vaccination: Vaccine intentions of parents of children aged 10 to 11s in Normandy schools after an information campaign during the 2015-2016 school year. La Presse Médicale, 48(12), E369–E381. https://doi.org/10.1016/j.lpm.2019.10.001
   PubMed Web of Science ®Google Scholar
• Karlas, A., Berre, S., Couderc, T., Varjak, M., Braun, P., Meyer, M., Gangneux, N., Karo-Astover, L., Weege, F., Raftery, M., Schönrich, G., Klemm, U., Wurzlbauer, A., Bracher, F., Merits, A., Meyer, T. F., & Lecuit, M. (2016). A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs. Nature Communications, 7, 11320. https://doi.org/10.1038/ncomms11320
   PubMed Web of Science ®Google Scholar
• Kattel, V., Sarraf, D. P., & Agrawal, Y. (2019). Doxycycline a game changer against acute undifferentiated febrile illness in the himalayas. Transactions of the Royal Society of Tropical Medicine and Hygiene, 113, S219–S219.
   Web of Science ®Google Scholar
• Kaur, P., & Chu, J. J. H. (2013). Chikungunya virus: An update on antiviral development and challenges. Drug Discov Today, 18(19–20), 969–983. https://doi.org/10.1016/j.drudis.2013.05.002
   PubMed Web of Science ®Google Scholar
• Kaur, P., Thiruchelvan, M., Lee, R. C. H., Chen, H., Chen, K. C., Ng, M. L., & Chu, J. J. H. (2013). Inhibition of Chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrobial Agents and Chemotherapy, 57(1), 155–167. https://doi.org/10.1128/AAC.01467-12
   PubMed Web of Science ®Google Scholar
• Keramagi, A. R., & Skariyachan, S. (2018). Prediction of binding potential of natural leads against the prioritized drug targets of chikungunya and dengue viruses by computational screening. 3 Biotech, 8(6):274. https://doi.org/10.1007/s13205-018-1303-2
   PubMedGoogle Scholar
• Khalili, M., Naderi, H. R., Salehnia, N., & Abiri, Z. (2016). Detection of Coxiella burnetii in acute undifferentiated febrile illnesses (AUFIs) in Iran. Tropical Doctor, 46(4), 221–224. https://doi.org/10.1177/0049475515624855
   PubMed Web of Science ®Google Scholar
• Khan, M., Santhosh, S. R., Tiwari, M., Rao, P. V. L., & Parida, M. (2010). Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. Journal of Medical Virology, 82(5), 817–824. https://doi.org/10.1002/jmv.21663
   PubMed Web of Science ®Google Scholar
• Kobinger, G. P., Figueredo, J. M., Rowe, T., Zhi, Y., Gao, G., Sanmiguel, J. C., Bell, P., Wivel, N. A., Zitzow, L. A., Flieder, D. B., Hogan, R. J., & Wilson, J. M. (2007). Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques. Vaccine, 25(28), 5220–5231. https://doi.org/10.1016/j.vaccine.2007.04.065
   PubMed Web of Science ®Google Scholar
• Kumar, D., Kumari, K., Jayaraj, A., & Singh, P. (2020a). Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles. Journal of Biomolecular Structure and Dynamics., 30(10), 3018–3034.
   Google Scholar
• Kumar, D., Singh, P., Jayaraj, A., Kumar, V., Kumari, K., Chandra, R., & Ramappa, V. K. (2020b). Selective docking of pyranooxazoles against nsP2 of CHIKV eluted through isothermally and non-isothermally MD simulations. ChemistrySelect, 5(14), 4210–4220. https://doi.org/10.1002/slct.202000768
   Web of Science ®Google Scholar
• Kumar, D., Singh, P., Jayaraj, A., Kumar, V., Kumari, K., & Patel, R. (2019a). A theoretical model to study the interaction of erythro-noscapines with nsP3 protease of Chikungunya virus. ChemistrySelect, 4(17), 4892–4900. https://doi.org/10.1002/slct.201803360
   Web of Science ®Google Scholar
• Kumar, D., Singh, P., Jayaraj, A., Kumar, V., Kumari, K., & Patel, R. (2019b). A theoretical model to study the interaction of erythro‐noscapines with nsP3 protease of Chikungunya virus. ChemistrySelect, 4(17), 4892–4900. https://doi.org/10.1002/slct.201803360
   Web of Science ®Google Scholar
• Kumar, M., Topno, R. K., Dikhit, M. R., Bhawana, Sahoo, G. C., & Madhukar, M. (2019c). Molecular docking studies of chloroquine and its derivatives against P23(pro-zbd) domain of chikungunya virus: Implication in designing of novel therapeutic strategies. Journal of Cellular Biochemistry, 120(10), 18298–18308. https://doi.org/10.1002/jcb.29139
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lee, N., & Qureshi, S. T. (2013). Other Viral pneumonias: coronavirus, respiratory syncytial virus, adenovirus, hantavirus. Critical Care Clinics, 29(4), 1045–1068. https://doi.org/10.1016/j.ccc.2013.07.003
   PubMed Web of Science ®Google Scholar
• Lilley, C. E., Groutsi, F., Han, Z. Q., Anderson, P., Latchman, D. S., & Coffin, R. S. (2000). Multiply disabled herpes simplex virus vectors for gene delivery to the central nervous system. European Journal of Neuroscience, 12, 308–308.
   Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Liu, L. S., Zhang, Y. Q., Liu, G. Z., Li, W., Zhang, X. Z., & Zanchetti, A. (2006). FEVER study: A trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines – Reply. Journal of Hypertension, 24(6), 1215–1216. https://doi.org/10.1097/01.hjh.0000226216.26431.7b
   Web of Science ®Google Scholar
• Liu, Q., Xiong, H-r., Lu, L., Liu, Y-y., Luo, F., Hou, W., & Yang, Z-q. (2013). Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection. Acta Pharmacologica Sinica, 34(8), 1075–1083. https://doi.org/10.1038/aps.2013.54
   PubMed Web of Science ®Google Scholar
• Lloyd, J., Copaciu, R., Yahyabeik, A., DeWit, C., Cummings, K., Lacey, M., & Su, Q. (2019). Characterization of polyclonal antibodies to herpes simplex virus types 1 and 2. Journal of Histotechnology, 42(4), 202–214. https://doi.org/10.1080/01478885.2019.1683132
   PubMed Web of Science ®Google Scholar
• Lohidakshan, K., Rajan, M., Ganesh, A., Paul, M., & Jerin, J. (2018). Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity. Bangladesh Journal of Pharmacology, 13(1), 23–29. https://doi.org/10.3329/bjp.v13i1.33625
   Web of Science ®Google Scholar
• Lopez-Tapia, F., Lou, Y., Brotherton-Pleiss, C., Kuglstatter, A., So, S. S., & Kondru, R. (2019). A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation. Bioorganic & Medicinal Chemistry Letters, 29(9), 1074–1078. https://doi.org/10.1016/j.bmcl.2019.03.001
   PubMed Web of Science ®Google Scholar
• Mackenzie, I. S., MacDonald, T. M., Shakir, S., Dryburgh, M., Mantay, B. J., McDonnell, P., & Layton, D. (2012). Influenza H1N1 (swine flu) vaccination: A safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology, 73(5), 801–811. https://doi.org/10.1111/j.1365-2125.2011.04142.x
   PubMed Web of Science ®Google Scholar
• Macy, E., Bernstein, J. A., Castells, M. C., Gawchik, S. M., Lee, T. H., Settipane, R. A., Simon, R. A., Wald, J., & Woessner, K. M. (2007). Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: A practice paper. Annals of Allergy Asthma & Immunology, 98(2), 172–174. https://doi.org/10.1016/S1081-1206(10)60692-8
   PubMed Web of Science ®Google Scholar
• Madhukar, G., & Subbarao, N. (2019). Identification of potent and novel phosphatidylinositol 3-Kinase catalytic subunit alpha inhibitors: A structure-based drug design approach. Journal of Biomolecular Structure & Dynamics, 37, 28–29.
   Web of Science ®Google Scholar
• Mahajan, D. T., Masand, V. H., Patil, K. N., Ben Hadda, T., & Rastija, V. (2013). Integrating GUSAR and QSAR analyses for antimalarial activity of synthetic prodiginines against multi drug resistant strain. Medicinal Chemistry Research, 22(5), 2284–2292. https://doi.org/10.1007/s00044-012-0223-7
   Web of Science ®Google Scholar
• Masand, V. H., Mahajan, D. T., Patil, K. N., Hadda, T. B., Youssoufi, M. H., Jawarkar, R. D., & Shibi, I. G. (2013). Optimization of antimalarial activity of synthetic prodiginines: QSAR, GUSAR, and CoMFA analyses. Chemical Biology & Drug Design, 81(4), 527–536. https://doi.org/10.1111/cbdd.12099
   PubMed Web of Science ®Google Scholar
• Mills, N. (2006). ChemDraw ultra 10.0. Journal of the American Chemical Society, 128(41), 13649–13650. https://doi.org/10.1021/ja0697875
   Web of Science ®Google Scholar
• Moizéis, R. N. C., Fernandes, T. A. A. d M., Guedes, P. M. d M., Pereira, H. W. B., Lanza, D. C. F., Azevedo, J. W. V. d., Galvão, J. M. d A., & Fernandes, J. V. (2018). Chikungunya fever: A threat to global public health. Pathogens and Global Health, 112(4), 182–194. https://doi.org/10.1080/20477724.2018.1478777
   PubMed Web of Science ®Google Scholar
• Mooers, B. H. M. (2018). Tools and methods to ease the development of scripts for making figures in PyMOL. Acta Crystallographica Section A Foundations and Advances, 74(a1), A423–A423. https://doi.org/10.1107/S0108767318095776
   Google Scholar
• Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017). Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Research, 142, 148–157. https://doi.org/10.1016/j.antiviral.2017.03.014
   PubMed Web of Science ®Google Scholar
• Moutelikova, R., Prodelalova, J., & Dufkova, L. (2015). Diversity of VP7, VP4, VP6, NSP2, NSP4, and NSP5 genes of porcine rotavirus C: Phylogenetic analysis and description of potential new VP7, VP4, VP6, and NSP4 genotypes. Archives of Virology, 160(7), 1715–1727.
   PubMed Web of Science ®Google Scholar
• Mukherjee, G., & Jayaram, B. (2013). A rapid identification of hit molecules for target proteins via physico-chemical descriptors. Physical Chemistry Chemical Physics: PCCP, 15(23), 9107–9116. https://doi.org/10.1039/c3cp44697b
   PubMed Web of Science ®Google Scholar
• Mullick, S., Das, S., Guha, S. K., Bera, D. K., Sengupta, S., Roy, D., Saha, P., Biswas, A., Das, M., Ray, K., Kundu, P. K., & Maji, A. K. (2011). Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India. Tropical Medicine & International Health: TM & IH, 16(8), 929–935. https://doi.org/10.1111/j.1365-3156.2011.02799.x
   PubMed Web of Science ®Google Scholar
• Narwal, M., Singh, H., Pratap, S., Malik, A., Kuhn, R. J., Kumar, P., & Tomar, S. (2018). Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site. International Journal of Biological Macromolecules, 116, 451–462. https://doi.org/10.1016/j.ijbiomac.2018.05.007
   PubMed Web of Science ®Google Scholar
• Nguyen, P. T. V., Yu, H. B., & Keller, P. A. (2014). Discovery of in silico hits targeting the nsP3 macro domain of Chikungunya virus. Journal of Molecular Modeling, 20(5), 2216. https://doi.org/10.1007/s00894-014-2216-6
   PubMed Web of Science ®Google Scholar
• Nguyen, P. T. V., Yu, H. B., & Keller, P. A. (2015). Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches. Journal of Molecular Graphics & Modelling, 57, 1–8. https://doi.org/10.1016/j.jmgm.2015.01.001
   PubMed Web of Science ®Google Scholar
• Nothias-Scaglia, L.-F., Retailleau, P., Paolini, J., Pannecouque, C., Neyts, J., Dumontet, V., Roussi, F., Leyssen, P., Costa, J., & Litaudon, M. (2014). Jatrophane diterpenes as inhibitors of chikungunya virus replication: Structure-activity relationship and discovery of a potent lead. Journal of Natural Products, 77(6), 1505–1512. https://doi.org/10.1021/np500271u
   PubMed Web of Science ®Google Scholar
• Nyari, N., Maan, H. S., Sharma, S., Pandey, S. N., & Dhole, T. N. (2016). Identification and genetic characterization of chikungunya virus from Aedes mosquito vector collected in the Lucknow district, North India. Acta Tropica, 158, 117–124. https://doi.org/10.1016/j.actatropica.2016.02.019
   PubMed Web of Science ®Google Scholar
• Ogihara, N., & Haley-Vicente, D. (2002). Protein target discovery and characterization - DS modeling and discovery studio streamline target discovery. Genetic Engineering News, 22(21), 77.
   Google Scholar
• Oo, A., Hassandarvish, P., Chin, S. P., Lee, V. S., Abu Bakar, S., & Zandi, K. (2016). Silico study on anti-Chikungunya virus activity of hesperetin. PeerJ, 4, e2602. https://doi.org/10.7717/peerj.2602
   PubMed Web of Science ®Google Scholar
• Park, E., & Griffin, D. E. (2009). The nsP3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice. Virology, 388(2), 305–314. https://doi.org/10.1016/j.virol.2009.03.031
   PubMed Web of Science ®Google Scholar
• Peters, M. J., Woolfall, K., Khan, I., Deja, E., Mouncey, P. R., Wulff, J., Mason, A., Agbeko, R. S., Draper, E. S., Fenn, B., Gould, D. W., Koelewyn, A., Klein, N., Mackerness, C., Martin, S., O’Neill, L., Ray, S., Ramnarayan, P., Tibby, S., … Rowan, K. M, the FEVER Investigators on behalf of the Paediatric Intensive Care Society Study Group (PICS-SG) (2019). Permissive versus restrictive temperature thresholds in critically ill children with fever and infection: A multicentre randomized clinical pilot trial. Critical Care, 23, 1–19. https://doi.org/10.1186/s13054-019-2354-4
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Pichler, V., Malandruccolo, C., Serini, P., Bellini, R., Severini, F., Toma, L., Di Luca, M., Montarsi, F., Ballardini, M., Manica, M., Petrarca, V., Vontas, J., Kasai, S., Della Torre, A., & Caputo, B. (2019). Phenotypic and genotypic pyrethroid resistance of Aedes albopictus, with focus on the 2017 chikungunya outbreak in Italy. Pest Management Science, 75(10), 2642–2651. https://doi.org/10.1002/ps.5369
   PubMed Web of Science ®Google Scholar
• Pohjala, L., Utt, A., Varjak, M., Lulla, A., Merits, A., Ahola, T., & Tammela, P. (2011). Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One, 6(12), e28923. https://doi.org/10.1371/journal.pone.0028923
   PubMed Web of Science ®Google Scholar
• Proskurnina, E. V., Izmailov, D. Y., Sozarukova, M. M., Zhuravleva, T. A., Leneva, I. A., & Poromov, A. A. (2020). Antioxidant potential of antiviral drug umifenovir. Molecules, 25(7), 1577. https://doi.org/10.3390/molecules25071577
   PubMed Web of Science ®Google Scholar
• Pshenichnaya, N. Y., Bulgakova, V. A., Lvov, N. I., Poromov, A. A., Selkova, E. P., Grekova, A. I., Shestakova, I. V., Maleev, V. V., & Leneva, I. A. (2019). Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR). Terapevticheskii Arkhiv, 91(3), 56–63. https://doi.org/10.26442/00403660.2019.03.000127
   PubMed Web of Science ®Google Scholar
• Ramière, C., Charre, C., Miailhes, P., Bailly, F., Radenne, S., Uhres, A.-C., Brochier, C., Godinot, M., Chiarello, P., Pradat, P., Cotte, L., Astrie, M., Augustin-Normand, C., François, B., Biron, F., Boibieux, A., Brochier, C., Braun, E., Brunel, F., … Uhres, A.-C, Lyon Acute Hepatitis Study Group (2019). Patterns of Hepatitis C virus transmission in human immunodeficiency virus (HIV)-infected and HIV-negative men who have sex with men. Clinical Infectious Diseases, 69(12), 2127–2135. https://doi.org/10.1093/cid/ciz160
   PubMed Web of Science ®Google Scholar
• Rashad, A. A., Mahalingam, S., & Keller, P. A. (2014). Chikungunya virus: Emerging targets and new opportunities for medicinal chemistry. Journal of Medicinal Chemistry, 57(4), 1147–1166. https://doi.org/10.1021/jm400460d
   PubMed Web of Science ®Google Scholar
• Robinson, M. C. (1955). An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-53. I. Clinical features. Transactions of the Royal Society of Tropical Medicine and Hygiene, 49(1), 28–32. https://doi.org/10.1016/0035-9203(55)90080-8
   PubMedGoogle Scholar
• Rothan, H. A., Bahrani, H., Abdulrahman, A. Y., Mohamed, Z., Teoh, T. C., Othman, S., Rashid, N. N., Rahman, N. A., & Yusof, R. (2016). Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo. Antiviral Research, 127, 50–56. https://doi.org/10.1016/j.antiviral.2016.01.006
   PubMed Web of Science ®Google Scholar
• Rudolph, T., Puls, M., Anderegg, C., Ebert, L., Broehan, M., Rudin, A., & Kowal, J. (2008). MARVIN: A medical research application framework based on open source software. Computer Methods and Programs in Biomedicine, 91(2), 165–174. https://doi.org/10.1016/j.cmpb.2008.04.007
   PubMed Web of Science ®Google Scholar
• Salvador, B., Zhou, Y. C., Michault, A., Muench, M. O., & Simmons, G. (2009). Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology, 393(1), 33–41. https://doi.org/10.1016/j.virol.2009.07.013
   PubMed Web of Science ®Google Scholar
• Sanchez, J. S., Canon, A. M., & Lombo, J. C. (2019). Sub-acute and chronic symptoms of the Chikungunya fever in a group of adults in Colombia. Biomedica, 39(3), 587–594. https://doi.org/10.7705/biomedica.4350
   PubMedGoogle Scholar
• Sangeetha, K., Purushothaman, I., & Rajarajan, S. (2017). Spectral characterisation, antiviral activities, in silico ADMET and molecular docking of the compounds isolated from Tectona grandis to chikungunya virus. Biomedicine & Pharmacotherapy, 87, 302–310.
   PubMed Web of Science ®Google Scholar
• Satheesh, G., Prabhu, N. P., & Venkataramana, M. (2014). 3D modeling of dengue virus NS4B and Chikungunya virus nsP4: Identification of a common drug target and designing a single antiviral inhibitor. Current Computer-Aided Drug Design, 10(4), 361–373. https://doi.org/10.2174/1573409911666150407161535
   PubMed Web of Science ®Google Scholar
• Satyanarayana, M. (2019). VACCINES Ebola vaccines were put to the test in the DRC. Chemical & Engineering News, 97(47), 42–42.
   Web of Science ®Google Scholar
• Sawicki, D. L., Perri, S., Polo, J. M., & Sawicki, S. G. (2006). Role for nsP2 proteins in the cessation of alphavirus minus-strand synthesis by host cells. Journal of Virology, 80(1), 360–371. https://doi.org/10.1128/JVI.80.1.360-371.2006
   PubMed Web of Science ®Google Scholar
• Schwartz, O., & Albert, M. L. (2010). Biology and pathogenesis of chikungunya virus. Nature Reviews. Microbiology, 8(7), 491–500. https://doi.org/10.1038/nrmicro2368
   PubMed Web of Science ®Google Scholar
• Seyedi, S. S., Shukri, M., Hassandarvish, P., Oo, A., Shankar, E. M., & Abubakar, S. (2016). Computational approach towards exploring potential anti-Chikungunya activity of selected flavonoids. Scientific Reports, 6, 1-8. https://doi.org/10.1038/srep24027
   Google Scholar
• Sharma, R., Fatma, B., Saha, A., Bajpai, S., Sistla, S., Dash, P. K., Parida, M., Kumar, P., & Tomar, S. (2016). Inhibition of chikungunya virus by picolinate that targets viral capsid protein. Virology, 498, 265–276. https://doi.org/10.1016/j.virol.2016.08.029
   PubMed Web of Science ®Google Scholar
• Silva, L. A., & Dermody, T. S. (2017). Chikungunya virus: Epidemiology, replication, disease mechanisms, and prospective intervention strategies. The Journal of Clinical Investigation, 127(3), 737–749. https://doi.org/10.1172/JCI84417
   PubMed Web of Science ®Google Scholar
• Silva, M. M. O., Tauro, L. B., Kikuti, M., Anjos, R. O., Santos, V. C., Gonçalves, T. S. F., Paploski, I. A. D., Moreira, P. S. S., Nascimento, L. C. J., Campos, G. S., Ko, A. I., Weaver, S. C., Reis, M. G., Kitron, U., & Ribeiro, G. S. (2019). Concomitant transmission of dengue, Chikungunya, and Zika viruses in Brazil: Clinical and epidemiological findings from surveillance for acute febrile illness. Clinical Infectious Diseases, 69(8), 1353–2238. https://doi.org/10.1093/cid/ciy1083
   PubMed Web of Science ®Google Scholar
• Simon, F., Javelle, E., Oliver, M., Leparc-Goffart, I., & Marimoutou, C. (2011). Chikungunya virus infection. Current Infectious Disease Reports, 13(3), 218–228. https://doi.org/10.1007/s11908-011-0180-1
   PubMedGoogle Scholar
• Singh, K. D., Kirubakaran, P., Nagarajan, S., Sakkiah, S., Muthusamy, K., Velmurgan, D., & Jeyakanthan, J. (2012). Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease. Journal of Molecular Modeling, 18(1), 39–51. https://doi.org/10.1007/s00894-011-1018-3
   PubMed Web of Science ®Google Scholar
• Singh, P., Kumar, D., Vishvakarma, V. K., Yadav, P., Jayaraj, A., & Kumari, K. (2019). Computational approach to study the synthesis of noscapine and potential of stereoisomers against nsP3 protease of CHIKV. Heliyon, 5(12), e02795. https://doi.org/10.1016/j.heliyon.2019.e02795
   PubMed Web of Science ®Google Scholar
• Singh, S. K., & Unni, S. K. (2011). Chikungunya virus: Host pathogen interaction. Reviews in Medical Virology, 21(2), 78–88. https://doi.org/10.1002/rmv.681
   PubMed Web of Science ®Google Scholar
• Singh, T., Biswas, D., & Jayaram, B. (2011). AADS-an automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors. Journal of Chemical Information and Modeling, 51(10), 2515–2527. https://doi.org/10.1021/ci200193z
   PubMed Web of Science ®Google Scholar
• Staples, J. E., Breiman, R. F., & Powers, A. M. (2009). Chikungunya fever: An epidemiological review of a re-emerging infectious disease. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 49(6), 942–948. https://doi.org/10.1086/605496
   PubMed Web of Science ®Google Scholar
• Vairo, F., Haider, N., Kock, R., Ntoumi, F., Ippolito, G., & Zumla, A. (2019). Chikungunya: Epidemiology, pathogenesis, clinical features, management, and prevention. Infectious Disease Clinics of North America, 33(4), 1003–1025. https://doi.org/10.1016/j.idc.2019.08.006
   PubMed Web of Science ®Google Scholar
• Vu, D. M., Jungkind, D., & Angelle Desiree, L. (2017). Chikungunya virus. Clinics in Laboratory Medicine, 37(2), 371–382.
   PubMed Web of Science ®Google Scholar
• Wang, Q., He, J. W., Wu, D., Wang, J., Yan, J., & Li, H. (2015). Interaction of alpha-cyperone with human serum albumin: Determination of the binding site by using discovery studio and via spectroscopic methods. Journal of Luminescence, 164, 81–85. https://doi.org/10.1016/j.jlumin.2015.03.025
   Web of Science ®Google Scholar
• Wang, Y. F., Sawicki, S. G., & Sawicki, D. L. (1994). Alphavirus Nsp3 functions to form replication complexes transcribing negative-strand RNA. Journal of Virology, 68(10), 6466–6475. https://doi.org/10.1128/JVI.68.10.6466-6475.1994
   PubMed Web of Science ®Google Scholar
• Weaver, S. C. (2014). Arrival of Chikungunya virus in the New World: Prospects for spread and impact on public health. PLoS Neglected Tropical Diseases, 8(6), e2921. https://doi.org/10.1371/journal.pntd.0002921
   PubMed Web of Science ®Google Scholar
• Wichit, S., Hamel, R., Bernard, E., Talignani, L., Diop, F., Ferraris, P., Liegeois, F., Ekchariyawat, P., Luplertlop, N., Surasombatpattana, P., Thomas, F., Merits, A., Choumet, V., Roques, P., Yssel, H., Briant, L., & Missé, D. (2017). Imipramine inhibits Chikungunya virus replication in human skin fibroblasts through interference with intracellular cholesterol trafficking. Scientific Reports, 7(1), 3145. https://doi.org/10.1038/s41598-017-03316-5
   PubMedGoogle Scholar
• Wintachai, P., Kaur, P., Lee, R. C. H., Ramphan, S., Kuadkitkan, A., Wikan, N., Ubol, S., Roytrakul, S., Chu, J. J. H., & Smith, D. R. (2015). Activity of andrographolide against chikungunya virus infection. Scientific Reports, 5, 14179. https://doi.org/10.1038/srep14179
   PubMed Web of Science ®Google Scholar
• Wright, Z. V. F., Wu, N. C., Kadam, R. U., Wilson, I. A., & Wolan, D. W. (2017). Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin. Bioorganic & Medicinal Chemistry Letters, 27(16), 3744–3748. https://doi.org/10.1016/j.bmcl.2017.06.074
   PubMed Web of Science ®Google Scholar
• Wyles, D. L. (2013). Antiviral resistance and the future landscape of Hepatitis C virus infection therapy. The Journal of Infectious Diseases, 207(suppl_1), S33–S39. https://doi.org/10.1093/infdis/jis761
   PubMedGoogle Scholar
• Yadav, P. D., Patil, D. Y., & Mourya, D. T. (2018). Positivity of dengue and chikungunya among Crimean-Congo hemorrhagic fever-negative cases in India: 2013–2016. Journal of Infection and Public Health, 11(6), 900–901. https://doi.org/10.1016/j.jiph.2018.09.001
   PubMed Web of Science ®Google Scholar